NCT00392496 2014-05-15Sunitinib in Treating Patients With Relapsed or Refractory Diffuse or Mediastinal Large B-Cell LymphomaNational Cancer Institute (NCI)Phase 2 Completed19 enrolled 4 charts
NCT00890747 2014-03-17Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyNational Cancer Institute (NCI)Phase 1 Completed42 enrolled